ahlam1399
03-28-2016, 08:42 PM
Valeant CEO subpoenaed to testify before U.S. Senate panel
WASHINGTON (Reuters) - The chief executive of Valeant Pharmaceuticals International Inc, which is under scrutiny for dramatically hiking the price of older *****, has been summoned to testify at a U.S. congressional hearing on April 27, the panel said on Monday.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e8f021e/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=mxC3p0kVr3A:iUGWxm9qY3k:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=mxC3p0kVr3A:iUGWxm9qY3k:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=mxC3p0kVr3A:iUGWxm9qY3k:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=mxC3p0kVr3A:iUGWxm9qY3k:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=mxC3p0kVr3A:iUGWxm9qY3k:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/mxC3p0kVr3A
WASHINGTON (Reuters) - The chief executive of Valeant Pharmaceuticals International Inc, which is under scrutiny for dramatically hiking the price of older *****, has been summoned to testify at a U.S. congressional hearing on April 27, the panel said on Monday.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e8f021e/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=mxC3p0kVr3A:iUGWxm9qY3k:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=mxC3p0kVr3A:iUGWxm9qY3k:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=mxC3p0kVr3A:iUGWxm9qY3k:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=mxC3p0kVr3A:iUGWxm9qY3k:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=mxC3p0kVr3A:iUGWxm9qY3k:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/mxC3p0kVr3A